Authors:
Giacchetti, S
Perpoint, B
Zidani, R
Le Bail, N
Faggiuolo, R
Focan, C
Chollet, P
Llory, JF
Letourneau, Y
Coudert, B
Bertheaut-Cvitkovic, F
Larregain-Fournier, D
Le Rol, A
Walter, S
Adam, R
Misset, JL
Levi, F
Citation: S. Giacchetti et al., Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer, J CL ONCOL, 18(1), 2000, pp. 136-147
Authors:
Giacchetti, S
Itzhaki, M
Gruia, G
Adam, R
Zidani, R
Kunstlinger, F
Brienza, S
Alafaci, E
Bertheault-Cvitkovic, F
Jasmin, C
Reynes, M
Bismuth, H
Misset, JL
Levi, F
Citation: S. Giacchetti et al., Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery, ANN ONCOL, 10(6), 1999, pp. 663-669
Authors:
Levi, F
Zidani, R
Brienza, S
Dogliotti, L
Perpoint, B
Rotarski, M
Letourneau, Y
Llory, JF
Chollet, P
Le Rol, A
Focan, C
Citation: F. Levi et al., A multicenter evaluation of intensified, ambulatory, chronomodulated chemotherapy with oxaliplatin, 5-fluorouracil, and leucovorin as initial treatment of patients with metastatic colorectal carcinoma, CANCER, 85(12), 1999, pp. 2532-2540